DA

Dhirendra Alias Abhay Rajnikant Shah

Active Director Director DIN 02361811
DIN 02361811 First appointment Nov 1983 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Total affiliations 5 Since Nov 1983
Shareholding value •••• Premium profile

About Dhirendra Alias Abhay Rajnikant Shah

Data last updated:

Dhirendra Alias Abhay Rajnikant Shah is a Director at Sahib Singh Agencies (Bombay) Private Limited (since 1983), Designated Partner at Grameen Pharma Llp (since 2012) and Director at Peak Agencies Pvt Ltd (since 1995), and holds 2 more current directorships. The companies operate in Pharma. The 4 current companies with reported revenue have a combined latest revenue of ₹36.49 Cr; the largest is Sahib Singh Agencies (Bombay) Private Limited at ₹28.30 Cr (FY 2022).

DIN 02361811
Primary Designation Director
Industry Pharma
First Appointment 01 Nov 1983
Oldest Company Age 73 yrs
Largest company Sahib Singh Agencies (Bombay) Private Limited · ₹28.30 Cr (FY 2022)
Combined revenue ₹36.49 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Nov 19831953₹28.30 Cr (FY 2022)Active
Designated Partner17 Apr 20122012₹7.59 Cr (FY 2024)Active
Peak Agencies Pvt Ltd U51900MH1987PTC044742
Director13 Jan 19951987₹45.4 Lakh (FY 2021)Active
Director30 Mar 20192019₹14.7 Lakh (FY 2024)Active
Kamalaa Llp ACU-0590
Designated Partner06 Jan 20262026Active

Directorship timeline

Open interactive timeline →
Sahib Singh Agencies (Bombay) Private Limited
Peak Agencies Pvt Ltd
Federation Of Pharmaceutical And Allied Products Merchant Exporters
Grameen Pharma Llp
Premium access

Shareholding and investment profile for Dhirendra Alias Abhay Rajnikant Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dhirendra Alias Abhay Rajnikant Shah

Dhirendra Alias Abhay Rajnikant Shah currently holds 5 directorships: Sahib Singh Agencies (Bombay) Private Limited (Director, since 01 Nov 1983, revenue ₹28.30 Cr (FY 2022)); Grameen Pharma Llp (Designated Partner, since 17 Apr 2012, revenue ₹7.59 Cr (FY 2024)); Peak Agencies Pvt Ltd (Director, since 13 Jan 1995, revenue ₹45.4 Lakh (FY 2021)); Federation Of Pharmaceutical And Allied Products Merchant Exporters (Director, since 30 Mar 2019, revenue ₹14.7 Lakh (FY 2024)); Kamalaa Llp (Designated Partner, since 06 Jan 2026).

Dhirendra Alias Abhay Rajnikant Shah was first appointed on 01 Nov 1983 as Director at Sahib Singh Agencies (Bombay) Private Limited. The most recent appointment on record is 06 Jan 2026 at Kamalaa Llp.

The 4 current companies of Dhirendra Alias Abhay Rajnikant Shah that report revenue have a combined latest revenue of ₹36.49 Cr: Sahib Singh Agencies (Bombay) Private Limited ₹28.30 Cr (FY 2022); Grameen Pharma Llp ₹7.59 Cr (FY 2024); Peak Agencies Pvt Ltd ₹45.4 Lakh (FY 2021); Federation Of Pharmaceutical And Allied Products Merchant Exporters ₹14.7 Lakh (FY 2024).

The current boards of Dhirendra Alias Abhay Rajnikant Shah's companies include Devendra Atul Rajnikant Shah (Sahib Singh Agencies (Bombay) Private Limited), Keval Dhirendra Shah (Grameen Pharma Llp), Ashish Niranjan Shah (Federation Of Pharmaceutical And Allied Products Merchant Exporters), Hemal Kamlesh Shah (Federation Of Pharmaceutical And Allied Products Merchant Exporters), Kamlesh Premchand Shah (Federation Of Pharmaceutical And Allied Products Merchant Exporters), Niren Mansukhlal Shah (Federation Of Pharmaceutical And Allied Products Merchant Exporters), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available